中文 | English
Return
Total: 30 , 1/3
Show Home Prev Next End page: GO
Author:(Quanlin GUAN)

1.Regulatory T cell and tumor immunity

Yuanli ZHANG ; Quanlin GUAN ; Bingdong ZHU

Journal of International Oncology 2012;39(1):8-11

2.Anticancer based on glycolysis pathway in tumor cells

Qianqian WANG ; Quanlin GUAN ; Bingdong ZHU

Journal of International Oncology 2011;38(12):914-916

3.Assessment of the necessary excision of normal parenchyma tissue in nephron-sparing surgery for renal cell carcinoma

Quanlin LI ; Hongwei GUAN ; Qiuping ZHANG

Chinese Journal of Urology 2000;0(12):-

4.Study of the genesis of multicentricity in renal cell carcinoma

Quanlin LI ; Hongwei GUAN ; Qiuping ZHANG

Chinese Journal of Urology 2001;0(04):-

5.Detection of CK-19 mRNA in peripheral blood from breast cancer patients by reverse transcription polymerase chain reaction

Quanlin GUAN ; Jiying TAN ; Xiaowei WANG

China Oncology 1998;0(04):-

6.Efficacy of VEGF and VEGFR pathway inhibitors in the treatment of advanced gastric cancer

Maoji LI ; Lei JIANG ; Quanlin GUAN

Journal of International Oncology 2017;44(5):393-396

7.Impact of margin size on patients' long-term effect after nephron sparing surgery for early localized renal cell carcinoma

Quanlin LI ; Hongwei GUAN ; Jie QIN ; Tao JIANG ; Xishuang SONG

Chinese Journal of Urology 2012;33(7):489-491

8.Aspirin for the prevention of colorectal adenomas: a systematic review

Yuanli ZHANG ; Quanlin GUAN ; Qianqian WANG ; Shuxun SHI

Journal of International Oncology 2011;38(12):943-947

9.Cancer stem cells and their isolation and identification

Na WANG ; Quanlin GUAN ; Bingdong ZHU ; Yi ZNANG

Cancer Research and Clinic 2010;22(2):138-140

10.Meta-analysis of the association between GSTT1 and the susceptibility to colorectal cancer among ;Chinese population

Tianning YANG ; Da ZHAO ; Shoucheng MA ; Quanlin GUAN

Journal of International Oncology 2015;(10):743-746

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 30 , 1/3 Show Home Prev Next End page: GO